Get startedLog in
    Picture of Maze Therapeutics logo

    MAZE — Maze Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Maze Therapeutics valued at $690.4 million as shares rise marginally in market debut

    Picture of Maze Therapeutics logoMaze Therapeutics
    31/01/2025 17:25
    Jan 31 (Reuters) - Shares of Maze Therapeutics  MAZE.O 
rose nearly 1% in their Nasdaq debut on Friday, valuing the
kidney disease drug developer at $690.37 million.
   

 (Reporting by Ateev Bhandari in Bengaluru; Editing by Alan
Barona)
 ((Ateev.Bhandari@thomsonreuters.com))

    Recent news on Maze Therapeutics

    See all news